Charis Kalogirou

1.0k total citations
54 papers, 654 citations indexed

About

Charis Kalogirou is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cancer Research. According to data from OpenAlex, Charis Kalogirou has authored 54 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 19 papers in Surgery and 16 papers in Cancer Research. Recurrent topics in Charis Kalogirou's work include Renal cell carcinoma treatment (16 papers), Bladder and Urothelial Cancer Treatments (11 papers) and MicroRNA in disease regulation (8 papers). Charis Kalogirou is often cited by papers focused on Renal cell carcinoma treatment (16 papers), Bladder and Urothelial Cancer Treatments (11 papers) and MicroRNA in disease regulation (8 papers). Charis Kalogirou collaborates with scholars based in Germany, Switzerland and Italy. Charis Kalogirou's co-authors include H. Riedmiller, Markus Krebs, Burkhard Kneitz, Daniel Vergho, Martin Spahn, Susanne Kneitz, Arkadius Kocot, Hubert Kübler, Evelyne Lerut and Claus Jürgen Scholz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Charis Kalogirou

41 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charis Kalogirou Germany	14	341	324	229	122	100	54	654
Masaki Shimbo Japan	14	162 0.5×	101 0.3×	484 2.1×	113 0.9×	101 1.0×	51	672
Guoping Ren China	15	250 0.7×	217 0.7×	314 1.4×	181 1.5×	61 0.6×	40	654
Antonio Fernández‐Serra Spain	15	318 0.9×	279 0.9×	332 1.4×	180 1.5×	40 0.4×	53	712
Zofia Kołosza Poland	16	180 0.5×	166 0.5×	109 0.5×	204 1.7×	102 1.0×	60	613
Liancheng Fan China	15	217 0.6×	201 0.6×	402 1.8×	270 2.2×	61 0.6×	38	691
Ken-ichi Tobisu Japan	10	164 0.5×	108 0.3×	252 1.1×	88 0.7×	107 1.1×	17	438
Ding-Wei Ye China	12	207 0.6×	157 0.5×	267 1.2×	112 0.9×	126 1.3×	20	509
Toshikazu Okaneya Japan	12	141 0.4×	47 0.1×	152 0.7×	124 1.0×	124 1.2×	51	423
In Ae Park South Korea	12	186 0.5×	241 0.7×	88 0.4×	319 2.6×	63 0.6×	18	605
Harri Visapää Finland	12	300 0.9×	112 0.3×	389 1.7×	95 0.8×	110 1.1×	30	634

Countries citing papers authored by Charis Kalogirou

Since Specialization

Citations

This map shows the geographic impact of Charis Kalogirou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charis Kalogirou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charis Kalogirou more than expected).

Fields of papers citing papers by Charis Kalogirou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charis Kalogirou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charis Kalogirou. The network helps show where Charis Kalogirou may publish in the future.

Co-authorship network of co-authors of Charis Kalogirou

This figure shows the co-authorship network connecting the top 25 collaborators of Charis Kalogirou. A scholar is included among the top collaborators of Charis Kalogirou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charis Kalogirou. Charis Kalogirou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kalogirou, Charis, Simon Weber, Anna Katharina Seitz, et al.. (2025). Radioligand treatment with [177Lu]Lu-PSMA I&T in elderly Patients - Safety, efficacy, and prognostic factors for survival. European Journal of Nuclear Medicine and Molecular Imaging. 53(3). 1469–1478. 1 indexed citations

Weber, Justus, Charis Kalogirou, Jörg Lehmann, et al.. (2025). ROR2-specific CAR T cells are effective against hematologic and solid tumors and well tolerated in mice. Cell Reports Medicine. 6(10). 102400–102400.

Kalogirou, Charis, et al.. (2025). Propensity-Score-Based Comparative Analysis of Transperitoneal and Retroperitoneal Approaches in Open and Minimally Invasive Renal Surgery: Impact on Operative Outcomes. Urologia Internationalis. 110(1). 28–37.

Kalogirou, Charis, Markus Krebs, Andreas Steven Kunz, et al.. (2025). Spatial transcriptomic profiling of metastatic renal cell carcinoma identifies chemokine-driven macrophage and CD8+ T-cell interactions predictive of immunotherapy response. Journal for ImmunoTherapy of Cancer. 13(10). e012991–e012991.

Garcia, Cristina Cano, Benedikt Hoeh, Séverine Banek, et al.. (2024). First-Line Immune Combination Therapies for Nonclear Cell Versus Clear Cell Metastatic Renal Cell Carcinoma: Real-World Multicenter Data From Germany. Clinical Genitourinary Cancer. 22(4). 102112–102112. 3 indexed citations

Seitz, Anna Katharina, et al.. (2024). Refluxing versus Non-Refluxing Ureteric Implantation in Continent Cutaneous Urinary Diversion: A Propensity-Scored Comparison regarding Long-Term Renal, Metabolic, and Functional Outcomes of Patients with Ileocecal Pouch. Urologia Internationalis. 109(1). 1–7.

Kalogirou, Charis, Helge Täubert, Sven Wach, et al.. (2024). Preoperative geriatric assessment to predict functional outcome after major urologic operations: Results from a multicenter study. European Journal of Surgical Oncology. 50(12). 108693–108693.

Hoeh, Benedikt, Cristina Cano Garcia, Séverine Banek, et al.. (2023). Early CRP kinetics to predict long‐term efficacy of first‐line immune‐checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real‐world experience applying different CRP kinetics definitions. Clinical & Translational Immunology. 12(10). e1471–e1471. 7 indexed citations

Krebs, Markus, Florian Röhrig, Hubert Kübler, et al.. (2023). Metformin Regulates the miR-205/VEGFA Axis in Renal Cell Carcinoma Cells: Exploring a Clinical Synergism with Tyrosine Kinase Inhibitors. Urologia Internationalis. 108(1). 49–59. 2 indexed citations

10.

Hoeh, Benedikt, Niklas Klümper, Oliver Hahn, et al.. (2022). Comparison of First-Line Anti-PD-1-Based Combination Therapies in Metastatic Renal-Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort. Urologia Internationalis. 106(11). 1150–1157. 7 indexed citations

11.

Struck, Julian P., Marie C. Hupe, A. Heinisch, et al.. (2021). RLC score (R status, lymphovascular invasion, C-reactive protein) predicts survival following radical cystectomy for muscle-invasive bladder cancer. Aktuelle Urologie. 53(6). 545–551. 2 indexed citations

12.

Solimando, Antonio Giovanni, Alexander Kerscher, Max Bittrich, et al.. (2021). Subgroup-Independent Mapping of Renal Cell Carcinoma—Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries. Frontiers in Oncology. 11. 621278–621278. 30 indexed citations

13.

Kaymak, Irem, Werner Schmitz, Andrew D. Campbell, et al.. (2019). Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress. Cancer Research. 80(2). 189–203. 66 indexed citations

14.

Kocot, Arkadius, Charis Kalogirou, Daniel Vergho, & H. Riedmiller. (2017). Long‐term results of ileal ureteric replacement: a 25‐year single‐centre experience. British Journal of Urology. 120(2). 273–279. 50 indexed citations

15.

Riedmiller, H., Arkadius Kocot, & Charis Kalogirou. (2017). Serous‐lined, stapled pouch wall plication: initial results of a simple and quick novel continence mechanism in troubleshooting secondary to continent cutaneous urinary diversion. British Journal of Urology. 121(1). 155–159.

16.

Hofbauer, Sebastian, Charis Kalogirou, Florian Roghmann, et al.. (2017). [Modern networks : Topics in the working group "Bladder cancer research" of the GeSRU Academics].. PubMed. 56(2). 202–207.

17.

Kalogirou, Charis, et al.. (2016). Long-Term Outcome of Nephron-Sparing Surgery Compared to Radical Nephrectomy for Renal Cell Carcinoma ≥4 cm - A Matched-Pair Single Institution Analysis. Urologia Internationalis. 98(2). 138–147. 11 indexed citations

18.

Kalogirou, Charis, Andrey А. Svistunov, Markus Krebs, et al.. (2016). Maintenance monotherapy with Gemcitabine following cisplatin-based primary combination chemotherapy in surgically treated advanced urothelial carcinoma: A matched-pair single institution analysis. Molecular and Clinical Oncology. 4(4). 636–642. 6 indexed citations

19.

Kalogirou, Charis, Daniel W. Schafer, Markus Krebs, et al.. (2015). Metformin-Derived Growth Inhibition in Renal Cell Carcinoma Depends on miR-21-Mediated <b><i>PTEN</i></b> Expression. Urologia Internationalis. 96(1). 106–115. 30 indexed citations

20.

Kneitz, Burkhard, Markus Krebs, Charis Kalogirou, et al.. (2014). Survival in Patients with High-Risk Prostate Cancer Is Predicted by miR-221, Which Regulates Proliferation, Apoptosis, and Invasion of Prostate Cancer Cells by Inhibiting IRF2 and SOCS3. Cancer Research. 74(9). 2591–2603. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact